Edition:
India

Athenex Inc (ATNX.OQ)

ATNX.OQ on NASDAQ Stock Exchange Global Select Market

11.00USD
6 Aug 2020
Change (% chg)

-- (--)
Prev Close
$11.00
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
234,690
52-wk High
$19.00
52-wk Low
$5.63

Select another date:

Mon, Jun 22 2020

BRIEF-Athenex Announces $225 Million Loan Agreement With Oaktree

* ATHENEX INC - PORTION OF UPFRONT LOAN PROCEEDS BEING USED TO REPAY IN FULL EXISTING DEBT FACILITY

BRIEF-Athenex Says Entered Into $225 Million Senior Secured Loan Agreement

* ATHENEX INC - ON JUNE 19, ENTERED INTO $225 MILLION SENIOR SECURED LOAN AGREEMENT

BRIEF-Athenex Presents Interim Data From Oral Paclitaxel Phase Ii Study In Cutaneous Angiosarcoma At Asco20 Virtual Scientific Program

* ATHENEX PRESENTS INTERIM DATA FROM ORAL PACLITAXEL PHASE II STUDY IN CUTANEOUS ANGIOSARCOMA AT ASCO20 VIRTUAL SCIENTIFIC PROGRAM

BRIEF-Athenex Q1 Loss Per Share $0.24

* ATHENEX, INC. REPORTS FIRST QUARTER ENDED MARCH 31, 2020 FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE

BRIEF-Athenex On Track To Submit NDA For Oral Paclitaxel And Encequidar

* ATHENEX INC - ON TRACK TO SUBMIT NDA FOR ORAL PACLITAXEL AND ENCEQUIDAR Source text for Eikon: Further company coverage: (Reuters.Briefs@thomsonreuters.com)

BRIEF-Athenex Says Arrangement With CEO Johnson Lau, Whereby Lau To Receive Options To Buy Co's Shares In Lieu Of Portion Of Remaining Base Salary For 2020

* ATHENEX - ARRANGEMENT WITH CEO JOHNSON LAU, WHEREBY LAU TO RECEIVE OPTIONS TO BUY CO'S SHARES IN LIEU OF PORTION OF REMAINING BASE SALARY FOR 2020

BRIEF-Athenex Inc's Operational Plans Continue To Remain On Track

* ATHENEX INC - OPERATIONAL PLANS CONTINUE TO REMAIN ON TRACK

BRIEF-Athenex Announces FDA Acceptance For Filing Of U.S. NDA For Tirbanibulin Ointment In Actinic Keratosis

* ATHENEX ANNOUNCES FDA ACCEPTANCE FOR FILING OF U.S. NDA FOR TIRBANIBULIN OINTMENT IN ACTINIC KERATOSIS

BRIEF-Athenex, Inc. Reports Q4 Loss Per Share $0.28

* ATHENEX, INC. REPORTS FOURTH QUARTER AND YEAR ENDED DECEMBER 31, 2019 FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE

Select another date: